4.7 Article

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Multidisciplinary Sciences

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis

Karol Marwa et al.

Summary: This study summarized the evidence of therapeutic efficacy of commonly used artemisinin-based combinations for the treatment of uncomplicated P. falciparum malaria in Sub-Saharan Africa, showing high treatment success rates above the WHO threshold value.

PLOS ONE (2022)

Article Microbiology

Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017

Nelli Westercamp et al.

Summary: The study compared the efficacy of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) in the treatment of uncomplicated malaria. The results showed that both AL and DP were efficacious and well tolerated, but the efficacy of AL appeared to be waning.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Infectious Diseases

Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018

Benjamin Abuaku et al.

Summary: Since 2005, treatment failures for artemisinin-based combination therapy (ACT) for uncomplicated malaria in Ghana have remained below 5%, with predictors of failure including the type of ACT, day 3 parasitaemia, and day 1 axillary temperature of patients.

BMC INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

Chris Ebong et al.

Summary: In Uganda, DP remains highly effective and safe for the treatment of uncomplicated malaria, while monitoring of AL efficacy shows recurrent infections.

MALARIA JOURNAL (2021)

Article Public, Environmental & Occupational Health

Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial

Aline Uwimana et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)

Article Public, Environmental & Occupational Health

Efficacy of Artesunate/Amodiaquine in the Treatment of Uncomplicated Malaria among Children in Ghana

Benjamin K. Abuaku et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)

Review Medicine, General & Internal

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria

Babalwa Zani et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)

Editorial Material Immunology

Artemisinin Combination Therapy for Malaria: Beyond Good Efficacy

Ric N. Price et al.

CLINICAL INFECTIOUS DISEASES (2009)

Review Public, Environmental & Occupational Health

Efficacy and safety of dihydroartemisinin-piperaquine

H. Y. Myint et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2007)

Article Public, Environmental & Occupational Health

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children

Corine Karema et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)